Maria Brattsand

3.0k total citations
32 papers, 2.3k citations indexed

About

Maria Brattsand is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Maria Brattsand has authored 32 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Genetics and 6 papers in Cell Biology. Recurrent topics in Maria Brattsand's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Skin and Cellular Biology Research (6 papers) and Prostate Cancer Treatment and Research (5 papers). Maria Brattsand is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Skin and Cellular Biology Research (6 papers) and Prostate Cancer Treatment and Research (5 papers). Maria Brattsand collaborates with scholars based in Sweden, Australia and France. Maria Brattsand's co-authors include Torbjörn Egelrud, Kristina Stefansson, Åke Lundwall, Ylva Haasum, Marina Guerrin, Nathalie Jonca, Dominique Bernard, Michel Simon, Cécile Caubet and Rainer Schmidt and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical Journal.

In The Last Decade

Maria Brattsand

32 papers receiving 2.2k citations

Peers

Maria Brattsand
T Egelrud Sweden
Roman Szabo United States
Bertrand Favre Switzerland
Todd W. Ridky United States
Maria Brattsand
Citations per year, relative to Maria Brattsand Maria Brattsand (= 1×) peers Marina Guerrin

Countries citing papers authored by Maria Brattsand

Since Specialization
Citations

This map shows the geographic impact of Maria Brattsand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Brattsand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Brattsand more than expected).

Fields of papers citing papers by Maria Brattsand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Brattsand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Brattsand. The network helps show where Maria Brattsand may publish in the future.

Co-authorship network of co-authors of Maria Brattsand

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Brattsand. A scholar is included among the top collaborators of Maria Brattsand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Brattsand. Maria Brattsand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Semenas, Julius, Sofia Halin Bergström, Marie Lundholm, et al.. (2023). Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328. Cancers. 15(9). 2437–2437. 3 indexed citations
2.
Ylitalo, Erik Bovinder, Elin Thysell, Mattias Landfors, et al.. (2021). A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. Clinical Epigenetics. 13(1). 133–133. 21 indexed citations
3.
Brattsand, Maria. (2020). Doxycycline at Low Concentrations Could Influence Your Experimental Results When Working With Prostate Cancer Cell Lines. Biomedical Journal of Scientific & Technical Research. 28(2). 1 indexed citations
4.
Riley, Blake T., Simon J. de Veer, David E. Hoke, et al.. (2019). Potent, multi-target serine protease inhibition achieved by a simplified β-sheet motif. PLoS ONE. 14(1). e0210842–e0210842. 8 indexed citations
5.
Hartfield, Perry J., Peter J. Prentis, Joachim M. Surm, et al.. (2019). A Versatile and Robust Serine Protease Inhibitor Scaffold from Actinia tenebrosa. Marine Drugs. 17(12). 701–701. 9 indexed citations
6.
Kašpárek, Petr, Ivan Kanchev, Oldřích Benada, et al.. (2017). KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype. PLoS Genetics. 13(1). e1006566–e1006566. 64 indexed citations
7.
Veer, Simon J. de, Laetitia Furio, Joakim E. Swedberg, et al.. (2016). Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum. Journal of Investigative Dermatology. 137(2). 430–439. 50 indexed citations
8.
Brattsand, Maria, Kristina Stefansson, Thomas Hubiche, Stefan K. Nilsson, & Torbjörn Egelrud. (2009). SPINK9: A Selective, Skin-Specific Kazal-Type Serine Protease Inhibitor. Journal of Investigative Dermatology. 129(7). 1656–1665. 54 indexed citations
9.
Lundwall, Åke & Maria Brattsand. (2008). Kallikrein-related peptidases. Cellular and Molecular Life Sciences. 65(13). 2019–2038. 105 indexed citations
10.
Stefansson, Kristina, Maria Brattsand, Dirk Roosterman, et al.. (2007). Activation of Proteinase-Activated Receptor-2 by Human Kallikrein-Related Peptidases. Journal of Investigative Dermatology. 128(1). 18–25. 152 indexed citations
11.
Deraison, Céline, Chrystelle Bonnart, Frédéric Lopez, et al.. (2007). LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent Interaction. Molecular Biology of the Cell. 18(9). 3607–3619. 235 indexed citations
12.
Hachem, Jean‐Pierre, Fredrik Wågberg, Matthias Schmuth, et al.. (2006). Serine Protease Activity and Residual LEKTI Expression Determine Phenotype in Netherton Syndrome. Journal of Investigative Dermatology. 126(7). 1609–1621. 129 indexed citations
13.
Stefansson, Kristina, Maria Brattsand, Annelii Ny, Bo Glas, & Torbjörn Egelrud. (2006). Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biological Chemistry. 387(6). 761–8. 50 indexed citations
14.
Brattsand, Maria, et al.. (2005). A Proteolytic Cascade of Kallikreins in the Stratum Corneum. Journal of Investigative Dermatology. 124(1). 198–203. 241 indexed citations
15.
Egelrud, T, Maria Brattsand, Peter Kreutzmann, et al.. (2005). hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. British Journal of Dermatology. 153(6). 1200–1203. 93 indexed citations
16.
Caubet, Cécile, Nathalie Jonca, Maria Brattsand, et al.. (2004). Degradation of Corneodesmosome Proteins by Two Serine Proteases of the Kallikrein Family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. Journal of Investigative Dermatology. 122(5). 1235–1244. 392 indexed citations
17.
Brattsand, Maria, et al.. (2000). Stratum Corneum Tryptic Enzyme in Normal Epidermis: a Missing Link in the Desquamation Process?11The authors declared in writing to have no conflict of interest.. Journal of Investigative Dermatology. 114(1). 56–63. 171 indexed citations
18.
Bäckman, Assar, et al.. (1999). Molecular Cloning and Tissue Expression of the Murine Analog to Human Stratum Corneum Chymotryptic Enzyme. Journal of Investigative Dermatology. 113(2). 152–155. 11 indexed citations
19.
Brattsand, Maria & Torbjörn Egelrud. (1999). Purification, Molecular Cloning, and Expression of a Human Stratum Corneum Trypsin-like Serine Protease with Possible Function in Desquamation. Journal of Biological Chemistry. 274(42). 30033–30040. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026